ReviewEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2025
Navigating osteonecrosis of the femoral head: from diagnosis to innovative treatment techniques.
Review in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Deep learning in the diagnosis, staging, and prognosis of osteonecrosis of the femoral head: a systematic review.BMC musculoskeletal disorders · 2026Pooled it
- Effects of crutch-assisted walking on pain, gait, and hip function in early and middle-stage osteonecrosis: a randomized trial.Journal of orthopaedic translation · 2026Article
- Bilibili and TikTok as sources of medical information on osteonecrosis of the femoral head: A cross-platform content analysis.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeOsteonecrosis of the femoral head (ONFH) is a debilitating condition caused by disrupted blood supply, leading to bone tissue death, pain, and reduced mobility. The purpose of this review is to consolidate current knowledge of ONFH, focusing on treatment options and highlighting the potential of innovative therapies to optimize management and delay disease progression.
methodsThe authors performed a review of the current literature examining the clinical presentation, diagnostic imaging techniques, and both non-surgical and surgical treatment approaches for ONFH. The literature was summarized in a narrative review using sources from PubMed, SCOPUS, and Google Scholar, with a focus on studies providing current and emerging evidence relevant to clinical decision-making and therapeutic innovation.
resultsONFH diagnosis relies on a combination of clinical evaluation and imaging modalities such as radiographs (XRs) and magnetic resonance imaging. Early-stage ONFH can be managed with non-surgical options like biophysical stimulation and pharmacologic therapies to preserve joint function. Advanced cases often require surgical interventions, including core decompression, osteotomies, and autologous bone grafting, which restore the joint surface and delay progression to total hip arthroplasty. Emerging treatments, such as bone marrow aspirate concentrate, platelet-rich plasma, and osteochondral allograft, have shown promise in enhancing surgical outcomes and improving bone regeneration.
conclusionsONFH management requires a multidisciplinary approach tailored to disease stage and patient-specific factors. While early interventions focus on preserving joint integrity, advanced stages benefit from surgical techniques and innovative therapies. This review aims to improve the understanding of ONFH and facilitate accurate diagnosis and appropriate management, ultimately improving patient outcomes.
Indexed as
Identifiers
40707660What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.